Cargando…

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance

Vascular endothelial growth factor (VEGF) has become a major target in cancer treatment as it promotes tumor angiogenesis. Therapy with anti-VEGF antibody bevacizumab reportedly induces high levels of circulating VEGF which may potentially contribute to resistance. Based on animal or computational m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alidzanovic, Lejla, Starlinger, Patrick, Schauer, Dominic, Maier, Thomas, Feldman, Alexandra, Buchberger, Elisabeth, Stift, Judith, Koeck, Ulrike, Pop, Lorand, Gruenberger, Birgit, Gruenberger, Thomas, Brostjan, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302983/ https://www.ncbi.nlm.nih.gov/pubmed/27527865 http://dx.doi.org/10.18632/oncotarget.11084

Ejemplares similares

Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation
por: Starlinger, P, et al.
Publicado: (2012)

Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration
por: Schauer, Dominic, et al.
Publicado: (2014)

Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer
por: Schauer, Dominic, et al.
Publicado: (2012)

Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection
por: Haegele, Stefanie, et al.
Publicado: (2016)

Platelet-Stored Angiogenesis Factors: Clinical Monitoring Is Prone to Artifacts
por: Starlinger, Patrick, et al.
Publicado: (2011)

Deficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction
por: Haegele, Stefanie, et al.
Publicado: (2015)

The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy
por: Pereyra, D., et al.
Publicado: (2019)

VEGF blockade damages brain vessels
por: Bashyam, Hema
Publicado: (2008)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection
por: Haegele, Stefanie, et al.
Publicado: (2018)

Thrombocytes Correlate with Lymphangiogenesis in Human Esophageal Cancer and Mediate Growth of Lymphatic Endothelial Cells In Vitro
por: Schoppmann, Sebastian F., et al.
Publicado: (2013)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer
por: Thonhauser, Rebecca, et al.
Publicado: (2023)

Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells
por: Rusovici, Raluca, et al.
Publicado: (2011)

Does anti-VEGF bevacizumab improve survival in experimental sepsis?
por: Besnier, Emmanuel, et al.
Publicado: (2017)

Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF
por: Sharma, Rajesh K., et al.
Publicado: (2010)

Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab
por: Latzer, Pauline, et al.
Publicado: (2016)

Blocking VEGF by Bevacizumab Compromises Electrophysiological and Morphological Properties of Hippocampal Neurons
por: Latzer, Pauline, et al.
Publicado: (2019)

Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade
por: Do, Diana V., et al.
Publicado: (2012)

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
por: Varey, A H R, et al.
Publicado: (2008)

Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet
por: Karaman, Sinem, et al.
Publicado: (2014)

A pharmacokinetic binding model for bevacizumab and VEGF(165) in colorectal cancer patients
por: Panoilia, Eirini, et al.
Publicado: (2015)

Chronic VEGF Blockade Worsens Glomerular Injury in the Remnant Kidney Model
por: Machado, Flavia G., et al.
Publicado: (2012)

Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs
por: Ben-Batalla, Isabel, et al.
Publicado: (2015)

Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation
por: Brossa, Alessia, et al.
Publicado: (2015)

Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice
por: Soubéran, Aurélie, et al.
Publicado: (2019)

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
por: Dengler, Mirko, et al.
Publicado: (2017)

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
por: Michaelsen, Signe R, et al.
Publicado: (2018)

N-VEGF, the Autoregulatory Arm of VEGF-A
por: Katsman, Marina, et al.
Publicado: (2022)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

Clinical management of patients with complicated multifocal disease
por: Gruenberger, Thomas
Publicado: (2014)

Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
por: Jiang, Xiaodan, et al.
Publicado: (2015)

Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model
por: Masuda, Chinami, et al.
Publicado: (2017)

VEGF blockade enhances the antitumor effect of BRAF(V) (600E) inhibition
por: Comunanza, Valentina, et al.
Publicado: (2016)

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations
por: Kampougeris, George, et al.
Publicado: (2013)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
por: Corlan, Ana Silvia, et al.
Publicado: (2019)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qledjalbrmsrbq7ci9hg12iqpd